Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 174
Filtrar
1.
J Cancer Res Clin Oncol ; 150(8): 392, 2024 Aug 20.
Artículo en Inglés | MEDLINE | ID: mdl-39162837

RESUMEN

BACKGROUND: Primary cardiac synovial sarcoma is a rare condition with limited treatment options for advanced stages. Surgery and chemotherapy are currently the mainstay treatments; however, survival rates remain low. CASE PRESENTATION: A 64-year-old woman presenting with symptoms of chest tightness and shortness of breath was found to have an obstructive right atrial mass, along with pulmonary infarction and metastasis. She was ultimately diagnosed with advanced primary cardiac synovial sarcoma. Following surgery, the patient's symptoms improved, and she underwent chemotherapy and anti-angiogenic therapy, but unfortunately, her survival time was only 8 months. CONCLUSION:  This case report aims to enhance clinicians' understanding of the diagnosis and treatment of primary cardiac synovial sarcoma. Enhancing both survival outcomes and quality of life in individuals with primary cardiac synovial sarcoma continues to present a significant challenge.


Asunto(s)
Neoplasias Cardíacas , Infarto Pulmonar , Sarcoma Sinovial , Humanos , Sarcoma Sinovial/patología , Sarcoma Sinovial/complicaciones , Sarcoma Sinovial/diagnóstico , Femenino , Persona de Mediana Edad , Neoplasias Cardíacas/patología , Neoplasias Cardíacas/complicaciones , Infarto Pulmonar/patología , Infarto Pulmonar/etiología , Tabique Interatrial/patología
2.
Kyobu Geka ; 77(4): 311-314, 2024 Apr.
Artículo en Japonés | MEDLINE | ID: mdl-38644180

RESUMEN

The patient is a 76-year-old man. His chief complaint of chest pain led to a diagnosis of pericardial effusion of unknown cause, and pericardial drainage was performed. On the 30th day, chest pain appeared again. Echocardiography revealed a pericardial fluid reaccumulation and a substantial mass in the pericardial space. Surgical drainage was performed to find the cause. A hematoma/mass was present on the epicardium. The pericardial sac was filled with hematoma. The hematoma was removed, but part of the mass infiltrated close to the anterior descending branch of the left coronary artery, and removal of that part was abandoned. The intrapericardial hematoma and epicardium were submitted to pathology leading to the diagnosis of synovial sarcoma. The patient was discharged home 14 days after surgery.


Asunto(s)
Neoplasias Cardíacas , Derrame Pericárdico , Sarcoma Sinovial , Humanos , Masculino , Sarcoma Sinovial/complicaciones , Sarcoma Sinovial/cirugía , Sarcoma Sinovial/diagnóstico por imagen , Derrame Pericárdico/etiología , Derrame Pericárdico/diagnóstico por imagen , Derrame Pericárdico/cirugía , Anciano , Neoplasias Cardíacas/complicaciones , Neoplasias Cardíacas/cirugía , Neoplasias Cardíacas/diagnóstico por imagen , Recurrencia
4.
BMJ Case Rep ; 16(12)2023 Dec 02.
Artículo en Inglés | MEDLINE | ID: mdl-38042527

RESUMEN

A man in his 20s with a history of laryngeal synovial sarcoma presented with dyspnoea. Imaging revealed a large right ventricular (RV) mass, which was resected, and histological analysis indicated synovial sarcoma recurrence. Within 1 month of RV mass resection, the tumour progressed with paratracheal metastasis. The lumen was nearly obliterated, and right ventricular outflow tract (RVOT) obstruction led to rapid deterioration with mixed cardiogenic and obstructive shock. We present a rare case of primary laryngeal synovial sarcoma metastasising to the heart.


Asunto(s)
Insuficiencia Cardíaca , Neoplasias Cardíacas , Neoplasias Laríngeas , Laringe , Sarcoma Sinovial , Sarcoma , Masculino , Humanos , Sarcoma Sinovial/complicaciones , Sarcoma Sinovial/cirugía , Sarcoma Sinovial/patología , Neoplasias Laríngeas/complicaciones , Neoplasias Laríngeas/cirugía , Laringe/patología , Neoplasias Cardíacas/complicaciones , Neoplasias Cardíacas/diagnóstico por imagen , Neoplasias Cardíacas/cirugía , Melanoma Cutáneo Maligno
5.
Arch. argent. pediatr ; 121(3): e202202714, jun. 2023. ilus
Artículo en Inglés, Español | LILACS, BINACIS | ID: biblio-1436134

RESUMEN

El sarcoma sinovial pleuropulmonar (SSPP) es un tumor primario de pulmón, maligno, infrecuente en pediatría (prevalencia 0,1-0,5 %) que afecta predominantemente a adolescentes y adultos jóvenes. Se ha descrito una sobrevida global cercana al 30 % a los 5 años. Se reporta el caso de un paciente de 12 años de edad, previamente sano, que presentó tos, dolor torácico y disnea de comienzo súbito, como manifestación inicial de neumotórax izquierdo, el que persistió a los 4 días y requirió resección quirúrgica de lesión bullosa pulmonar. Se realizó diagnóstico histológico de sarcoma sinovial pleuropulmonar confirmado por estudio molecular, que evidenció la translocación cromosómica entre el cromosoma X y el 18: t(X;18) (p11.2;q11.2) de la pieza quirúrgica extirpada. Ante pacientes con neumotórax persistente o recidivante, es importante descartar causas secundarias, entre ellas, sarcoma sinovial pleuropulmonar. Su ominoso pronóstico determina la necesidad de arribar a un diagnóstico temprano e implementar un tratamiento agresivo


Pleuropulmonary synovial sarcoma (PPSS) is a primary malignancy of the lung, uncommon in pediatrics (prevalence: 0.1­0.5%) that predominantly affects adolescents and young adults. Overall survival has been reported to be close to 30% at 5 years. Here we report the case of a previously healthy 12-year-old male patient who presented with cough, chest pain, and dyspnea of sudden onset as initial manifestation of left pneumothorax, which persisted after 4 days and required surgical resection of pulmonary bullous lesion. A histological diagnosis of pleuropulmonary synovial sarcoma was made and confirmed by molecular study, which showed chromosomal translocation between chromosomes X and 18: t(X;18) (p11.2;q11.2) in the surgical specimen removed. In patients with persistent or recurrent pneumothorax, it is important to rule out secondary causes, including pleuropulmonary synovial sarcoma. Such poor prognosis determines the need for early diagnosis and aggressive treatment.


Asunto(s)
Humanos , Masculino , Niño , Neumotórax/complicaciones , Neumotórax/etiología , Sarcoma Sinovial/complicaciones , Sarcoma Sinovial/diagnóstico , Sarcoma Sinovial/patología , Neoplasias Pulmonares/complicaciones , Neoplasias Pulmonares/diagnóstico , Tos , Pulmón/patología
7.
Aging (Albany NY) ; 15(2): 567-582, 2023 01 30.
Artículo en Inglés | MEDLINE | ID: mdl-36719264

RESUMEN

OBJECTIVE: This study was performed to explore the prognostic relevance of structural maintenance of chromosomes 4 (SMC4) in pan-cancer and explore the association between SMC4 and immune infiltration of sarcoma. RESULTS: Elevated expression of SMC4 was detected in cancer tissues compared to normal tissue, which was confirmed in synovial sarcoma tissues with immunohistochemistry (IHC). Additionally, higher expression of SMC4 was connected to worse outcomes of sarcoma, gastric cancer, breast cancer, liver cancer or ovarian cancer. Moreover, SMC4 was positively connected to immune cell infiltrates in sarcoma. In addition, infiltrating immune cell markers including monocyte, TAM, M1 and M2 presented different SMC4-associated immune infiltration patterns. CONCLUSION: The results from our study showed that SMC4 was positively related to the prognosis and immunological status of sarcoma. SMC4 could be a potential biomarker for prognosis and immune cell infiltrates in sarcoma. METHODS: Several databases including ONCOMINE, GEPIA, and Kaplan-Meier Plotter were adopted to explore the expression pattern of SMC4 in sarcoma, which was confirmed by IHC. The GEPIA and TIMER datasets were adopted to investigate the associations between SMC4 and prognosis in various cancers, especially in sarcoma.


Asunto(s)
Proteínas Cromosómicas no Histona , Neoplasias , Sarcoma Sinovial , Sarcoma , Femenino , Humanos , Biomarcadores de Tumor , Proteínas Cromosómicas no Histona/genética , Pronóstico , Sarcoma/complicaciones , Sarcoma Sinovial/complicaciones , Neoplasias/complicaciones
8.
World J Surg Oncol ; 21(1): 24, 2023 Jan 30.
Artículo en Inglés | MEDLINE | ID: mdl-36710330

RESUMEN

Synovial sarcoma is a rare soft tissue sarcoma which frequently involves the upper or lower extremities. Soft tissue sarcomas including synovial sarcoma have a propensity to metastasize to the lungs, and there are very few reports of metastatic lesions in other locations.Here, we report a case of a 49-year-old patient who underwent neoadjuvant chemoradiation for an upper extremity synovial sarcoma and presented approximately 4 years later with abdominal pain and hemoperitoneum and was ultimately found to have metastatic synovial sarcoma involving the greater curvature of the stomach and surrounding peri-gastric soft tissue. We describe the multidisciplinary management of this complex patient presentation and propose that expanded surveillance imaging beyond that of the local tumor resection bed and the chest may be beneficial especially in tumors with high-risk features.


Asunto(s)
Sarcoma Sinovial , Sarcoma , Neoplasias de los Tejidos Blandos , Humanos , Persona de Mediana Edad , Sarcoma Sinovial/complicaciones , Sarcoma Sinovial/terapia , Hemoperitoneo/etiología , Hemoperitoneo/cirugía , Sarcoma/patología , Neoplasias de los Tejidos Blandos/patología , Extremidad Inferior/patología
9.
Arch Argent Pediatr ; 121(3): e202202714, 2023 06 01.
Artículo en Inglés, Español | MEDLINE | ID: mdl-36413217

RESUMEN

Pleuropulmonary synovial sarcoma (PPSS) is a primary malignancy of the lung, uncommon in pediatrics (prevalence: 0.1-0.5%) that predominantly affects adolescents and young adults. Overall survival has been reported to be close to 30% at 5 years. Here we report the case of a previously healthy 12-year-old male patient who presented with cough, chest pain, and dyspnea of sudden onset as initial manifestation of left pneumothorax, which persisted after 4 days and required surgical resection of pulmonary bullous lesion. A histological diagnosis of pleuropulmonary synovial sarcoma was made and confirmed by molecular study, which showed chromosomal translocation between chromosomes X and 18: t(X;18) (p11.2;q11.2) in the surgical specimen removed. In patients with persistent or recurrent pneumothorax, it is important to rule out secondary causes, including pleuropulmonary synovial sarcoma. Such poor prognosis determines the need for early diagnosis and aggressive treatment.


El sarcoma sinovial pleuropulmonar (SSPP) es un tumor primario de pulmón, maligno, infrecuente en pediatría (prevalencia 0,1-0,5 %) que afecta predominantemente a adolescentes y adultos jóvenes. Se ha descrito una sobrevida global cercana al 30 % a los 5 años. Se reporta el caso de un paciente de 12 años de edad, previamente sano, que presentó tos, dolor torácico y disnea de comienzo súbito, como manifestación inicial de neumotórax izquierdo, el que persistió a los 4 días y requirió resección quirúrgica de lesión bullosa pulmonar. Se realizó diagnóstico histológico de sarcoma sinovial pleuropulmonar confirmado por estudio molecular, que evidenció la translocación cromosómica entre el cromosoma X y el 18: t(X;18) (p11.2;q11.2) de la pieza quirúrgica extirpada. Ante pacientes con neumotórax persistente o recidivante, es importante descartar causas secundarias, entre ellas, sarcoma sinovial pleuropulmonar. Su ominoso pronóstico determina la necesidad de arribar a un diagnóstico temprano e implementar un tratamiento agresivo.


Asunto(s)
Neoplasias Pulmonares , Neumotórax , Sarcoma Sinovial , Masculino , Adolescente , Adulto Joven , Humanos , Niño , Neumotórax/etiología , Neumotórax/complicaciones , Sarcoma Sinovial/complicaciones , Sarcoma Sinovial/diagnóstico , Sarcoma Sinovial/patología , Neoplasias Pulmonares/complicaciones , Neoplasias Pulmonares/diagnóstico , Tos , Pulmón/patología
12.
Med Arch ; 77(6): 496-499, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-38313103

RESUMEN

Background: Synovial sarcoma is a rare and aggressive soft tissue malignancy most commonly arises from periarticular tissue of the extremities. Although several cases in the literature have reported different origins, primary pulmonary synovial sarcoma (PPSS) is an exceedingly rare and underrecognized entity, accounting for 0.5% of all lung malignancies. Clinical presentation includes chest pain, dyspnea, cough, and hemoptysis. The finding of hemothorax is a rare presentation and was barely reported in the literature. Due to its rarity and aggressive nature, the optimal treatment is unclear, while the mainstay remains surgical resection with chemo- and/or radiation therapy. Objective: To report a case of hemorrhagic effusion subsequently diagnosed with primary pulmonary synovial sarcoma with the main objective of enriching the literature regarding this rare malignancy. Case report: A 52-year-old male smoker with a background of coronary artery disease, hypertension, and diabetes mellitus was referred to our hospital. The patient presented with a history of chest pain, dyspnea, and massive right-sided pleural effusion. Laboratory investigations were unremarkable except for anemia. Chest x-ray showed a complete opacity on the right lower zone with right-sided pleural effusion. Thoracentesis was done and revealed hemorrhagic exudative effusion. Computed tomography (CT) scan showed a right heterogeneous lung mass compressing the medial segment of the middle lobe. Subsequently, the patient underwent bronchoscopy, which showed compression and edema on the right middle lobe bronchus with traces of blood coming from the right lower lobe. The patient underwent a right posterolateral thoracotomy, a fungating mass eroding the medial segment of the middle lobe was resected that was diagnosed as high-grade primary pulmonary synovial sarcoma. Radiotherapy was instituted. The patient died after two years due to recurrence. Conclusion: PPSS is an aggressive disease with poor prognostic outcomes, and Its presentation is almost similar to other lung malignancies. Meanwhile, there is no definitive management guideline, and most management depends on surgical resection if feasible with adjuvant chemo-radiation therapy.


Asunto(s)
Neoplasias Pulmonares , Derrame Pleural , Sarcoma Sinovial , Masculino , Humanos , Persona de Mediana Edad , Hemotórax/diagnóstico , Hemotórax/etiología , Hemotórax/terapia , Sarcoma Sinovial/complicaciones , Sarcoma Sinovial/diagnóstico , Sarcoma Sinovial/cirugía , Neoplasias Pulmonares/complicaciones , Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/terapia , Dolor en el Pecho/etiología , Disnea/etiología , Pulmón/patología
14.
Perm J ; 26(3): 94-102, 2022 09 14.
Artículo en Inglés | MEDLINE | ID: mdl-35939568

RESUMEN

BackgroundWhether the presenting symptom of pain vs mass impacts survival of early-stage synovial sarcoma is not known. Patients and MethodsThe authors investigated patients with early-stage extremity/trunk synovial sarcoma diagnosed from 2005 to 2017 at Kaiser Permanente Northern California for associations between the presenting symptom and survival. ResultsAmong 56 patients with early-stage extremity/trunk synovial sarcoma, median disease-free survival (DFS) was 20.3 months for the pain-only group (n = 19) vs 50.5 months for the mass ± pain group (n = 37) (p = 0.004), and median overall survival (OS) was 35.7 months vs 53.9 months (p = 0.009), respectively. Median DFS was 26.9 months for the pain ± mass group (n = 32) vs 48.6 months for the mass-only group (n = 24) (p = 0.047), whereas OS was not significantly different (49.6 vs. 53.6 months, p = 0.282). Pain at presentation was associated with a higher incidence of deep tumors and a higher risk of relapse. Cox regression model adjusting for age, sex, race, tumor location, tumor size, and wait-time to seek medical attention showed that pain at presentation was associated with 3-fold worse DFS and OS. ConclusionPain at presentation was an adverse risk factor for patients with early-stage extremity/trunk synovial sarcoma.


Asunto(s)
Leucemia Mieloide Aguda , Sarcoma Sinovial , Sarcoma , Extremidades/patología , Humanos , Dolor , Pronóstico , Recurrencia , Estudios Retrospectivos , Sarcoma/patología , Sarcoma Sinovial/complicaciones , Sarcoma Sinovial/patología
15.
JBJS Case Connect ; 12(3)2022 07 01.
Artículo en Inglés | MEDLINE | ID: mdl-35977038

RESUMEN

CASE: Three cases of atypical metatarsalgia are presented, all diagnosed with foot synovial sarcomas (SSs) at different stages of evolution, after a year of medical consultations. One case was treated with marginal excision without requiring bone excision; the second patient required amputation of the first ray; and the third patient, with advanced disease, required amputation through Chopart's joint. CONCLUSION: Metatarsalgia is a recurrent reason for consultation in orthopaedics. Even so, patients with persistent symptoms should be studied further in depth. Computed tomography or magnetic resonance imaging can detect tumor pathology, such as SS, of insidious development.


Asunto(s)
Metatarsalgia , Sarcoma Sinovial , Articulaciones Tarsianas , Amputación Quirúrgica/métodos , Pie/patología , Humanos , Metatarsalgia/diagnóstico por imagen , Metatarsalgia/etiología , Metatarsalgia/cirugía , Sarcoma Sinovial/complicaciones , Sarcoma Sinovial/diagnóstico por imagen , Sarcoma Sinovial/cirugía
17.
J Card Surg ; 36(8): 2992-2995, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-33982302

RESUMEN

INTRODUCTION: Primary cardiac synovial sarcoma is an exceedingly rare soft tissue malignant tumor, involving either the pericardium or chambers, with a striking male predominance, prevalently seen in the fourth decade. These tumours most commonly present as breathlessness on exertion. These patients readily exhibit gastrointestinal and systemic symptoms but sometimes the presentation can be fallacious. METHODS: A 37-year old male presented with fever, breathlessness on exertion and hematuria who was managed for dengue feverat another hospital. Patient also had features of right heart failure and congestive hepatomegaly. Patient was evaluated thoroughlyand diagnosed as right atrial tumour mass for which surgical resection was done. RESULTS: The tumour mass was diagnosed as right atrial biphasic synovial sarcoma after immunohistochemistry. Patient also had thrombocytopenia which was due to increased consumption of platelets. CONCLUSIONS: Right heart biphasic synovial sarcoma, arising from the tricuspid valve in association with thrombocytopenia and right heart failure is an extremely rare entity and that can have a deceptive presentation.


Asunto(s)
Neoplasias Cardíacas , Sarcoma Sinovial , Trombocitopenia , Adulto , Atrios Cardíacos/cirugía , Neoplasias Cardíacas/complicaciones , Neoplasias Cardíacas/diagnóstico , Neoplasias Cardíacas/cirugía , Humanos , Masculino , Sarcoma Sinovial/complicaciones , Sarcoma Sinovial/diagnóstico , Sarcoma Sinovial/cirugía , Trombocitopenia/etiología , Válvula Tricúspide
18.
Pathol Res Pract ; 222: 153418, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33819897

RESUMEN

Synovial sarcoma is an uncommon tumor of soft tissue, characterized by a specific SS18-SSX1/2/4 fusion gene. It is generally a lesion composed of monomorphic spindle cells, and can sometimes show variable epithelial differentiation. Here, we present the case of a young woman with a synovial sarcoma of the abdominal wall that showed an overwhelming (>90 %) epithelial glandular component mimicking adenocarcinoma, and only rare spindled areas. The diagnosis was confirmed by detection of targeted fusion transcripts associated with synovial sarcoma. We review the literature pertaining to synovial sarcoma, and we show that this case is only the sixth molecularly proven epithelial predominant synovial sarcoma in the literature. This report emphasizes the importance of molecular approaches in modern soft tissue pathology. Recognition of synovial sarcoma with predominant glandular component is imperative in order to avoid misdiagnosis of the tumor as metastatic adenocarcinoma, another type of sarcoma with epithelial differentiation, or a carcinoma with a sarcomatous component (sarcomatoid carcinoma), all of which have markedly different clinical management.


Asunto(s)
Adenocarcinoma/complicaciones , Adenocarcinoma/genética , Sarcoma Sinovial/complicaciones , Sarcoma Sinovial/genética , Adenocarcinoma/diagnóstico , Adulto , Biomarcadores de Tumor/genética , Femenino , Humanos , Proteínas de Fusión Oncogénica/genética , Sarcoma Sinovial/diagnóstico , Neoplasias de los Tejidos Blandos/genética , Neoplasias de los Tejidos Blandos/patología , Translocación Genética
19.
BMJ Case Rep ; 14(3)2021 Mar 18.
Artículo en Inglés | MEDLINE | ID: mdl-33737273

RESUMEN

Synovial sarcomas are most commonly localised in extremities, especially in the lower thigh and knee areas. Comprising less than 1% of all malignancies, retroperitoneal synovial sarcoma is very rare with primary synovial sarcoma of the kidney being even more infrequent and difficult to diagnose. We describe a case report of a renal synovial sarcoma in a young adult who was initially managed as a case of Wunderlich's syndrome secondary to what was believed to be a ruptured renal angiomyolipoma. After biopsy confirmation, the patient was eventually managed with neo-adjuvant chemotherapy followed by a right radical nephrectomy and right hepatectomy. Despite its rarity, synovial sarcoma should be considered as differential diagnosis of a bleeding retroperitoneal soft tissue mass detected in young adults.


Asunto(s)
Angiomiolipoma , Neoplasias Renales , Sarcoma Sinovial , Angiomiolipoma/cirugía , Humanos , Neoplasias Renales/complicaciones , Neoplasias Renales/diagnóstico , Neoplasias Renales/cirugía , Nefrectomía , Espacio Retroperitoneal/diagnóstico por imagen , Sarcoma Sinovial/complicaciones , Sarcoma Sinovial/diagnóstico , Sarcoma Sinovial/cirugía
20.
Medicine (Baltimore) ; 99(50): e23499, 2020 Dec 11.
Artículo en Inglés | MEDLINE | ID: mdl-33327288

RESUMEN

RATIONALE: Synovial sarcoma (SS) is a soft tissue neoplasm that rarely occurs in the vertebral body and should be considered in the differential diagnosis in patients with SS and vertebral lesions. SS often presents as a painless mass in the spine, which may undergo slow enlargement, resulting in sustained symptoms of neurologic deficit and pain. Due to the difficulty in differentiating between SS from other soft tissue tumors and metastatic tumors, careful histological confirmation is required for definite diagnosis. Furthermore, due to its malignancy, the appropriate treatment procedure for SS should be carefully considered. PATIENT CONCERNS: A 56-year-old female patient had low back pain. Radiological examination revealed bony erosion of the L-2 vertebral body, and no soft tissue mass around the lumbar spine. DIAGNOSIS: Histopathological and immunohistochemical examination revealed SS. INTERVENTIONS: The initial treatment of posterior laminectomy decompression and percutaneous vertebro plasty (PVP) was performed, however, this initial treatment course was inappropriate, but she eventually underwent L-2 complete resection and internal fixation. After the second surgery, she was treated by external beam radiation therapy. OUTCOMES: operation radiotherapy was finally performed. No local recurrence in L-2 vertebral body or distant metastasis was found at 1-year follow up postoperation; the neurologic symptom gradually relieved, and no other symptom was noted. And no local recurrence in L-2 vertebral body and distant metastasis was found in 1 year follow up postoperation. LESSONS: Solitary spinal SS is extremely rare. Early surgery for total resection and adjuvant radiotherapy/chemotherapy should be emphasized.


Asunto(s)
Vértebras Lumbares , Sarcoma Sinovial/diagnóstico , Neoplasias de la Columna Vertebral/diagnóstico , Terapia Combinada , Diagnóstico Diferencial , Femenino , Humanos , Laminectomía , Dolor de la Región Lumbar/etiología , Persona de Mediana Edad , Sarcoma Sinovial/complicaciones , Sarcoma Sinovial/diagnóstico por imagen , Sarcoma Sinovial/terapia , Neoplasias de la Columna Vertebral/complicaciones , Neoplasias de la Columna Vertebral/diagnóstico por imagen , Neoplasias de la Columna Vertebral/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...